Back
ProShares Ultra VIX Short-Term Futures ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
82
UVXY
ProShares Ultra VIX Short-Term Futures ETF
Last Price:
$25.63
Seasonality Move:
-17.18%
Buy
54
SRPT
Sarepta Therapeutics
Last Price:
$99.80
Seasonality Move:
6.73%
Buy
82
ProShares Ultra VIX Short-Term Futures ETF (UVXY)
is a Buy
Is ProShares Ultra VIX Short-Term Futures ETF a Buy, Sell or Hold?
-
The current ProShares Ultra VIX Short-Term Futures ETF [UVXY] share price is $27.61. The Score for UVXY is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
-
UVXY is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
54
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
UVXY Stock Price Chart
What is ProShares Ultra VIX Short-Term Futures ETF's stock price today?
-
The ProShares Ultra VIX Short-Term Futures ETF share price today is $27.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UVXY is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $100.71Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
UVXY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.56 | Buy |
Relative Strength Index (14 RSI): | 69.39 | Buy |
Chaikin Money Flow: | -13966446 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.52 - 22.72) | Buy |
Bollinger Bands (100): | (18.14 - 25.16) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.22 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | 544784 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (103.87 - 112.63) | Sell |
Bollinger Bands (100): | (110.05 - 127.23) | Sell |
UVXY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.28 | Buy |
20-day SMA: | 20.39 | Buy |
50-day SMA: | 19.98 | Buy |
200-day SMA: | 23.75 | Buy |
8-day EMA: | 23.64 | Buy |
20-day EMA: | 21.5 | Buy |
50-day EMA: | 20.68 | Buy |
200-day EMA: | 29.88 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.91 | Sell |
20-day SMA: | 106.68 | Sell |
50-day SMA: | 114.29 | Sell |
200-day SMA: | 126.68 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.89 | Sell |
50-day EMA: | 112.29 | Sell |
200-day EMA: | 121 | Sell |
ProShares Ultra VIX Short-Term Futures ETF Earnings Growth & UVXY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.
ProShares Ultra VIX Short-Term Futures ETF Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |